US Patent Issued to Beyond Barriers Therapeutics on July 28 for "Sublingual or buccal dosage forms comprising antioxidants for treatment of central nervous system disorders" (Illinois Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,058, issued on July 28, was assigned to Beyond Barriers Therapeutics Inc. (Glencoe, Ill.).

"Sublingual or buccal dosage forms comprising antioxidants for treatment of central nervous system disorders" was invented by Ryan Kole (Glencoe, Ill.), John Marshall (Glencoe, Ill.), Charles Polsky (Glencoe, Ill.), Brian Reinhardt (Glencoe, Ill.) and Thomas A. DeGregoris (Glencoe, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Sublingual or buccal dosage forms comprise at least one antioxidant compound, such as N-acetyl cysteine (NAC), or a pharmaceutically acceptable salt thereof. The sublingual or buccal dosage forms are administered for treating centr...